Search research articles
Contact Us
Filters
Showing results (41-50 of 179) with videos related to
Page
of 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2009
Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma
Sui Shen, Andres Forero, Ruby F Meredith, et al.
Annals of Hematology
|
January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma
Myron S Czuczman, Stephen Kahanic, Andres Forero, et al.
JCO Clinical Cancer Informatics
|
March 7, 2019
Visualization of Sequential Treatments in Metastatic Breast Cancer
Gabrielle B Rocque, Pravinkumar G Kandhare, Courtney P Williams, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)
Andres Forero-Torres, Jatin Shah, Tina Wood, et al.
Journal of Oncology Practice
|
May 19, 2016
Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials
Mona N Fouad, Aras Acemgil, Sejong Bae, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2019
Histone deacetylase inhibition promotes intratumoral CD8<sup>+</sup> T-cell responses, sensitizing murine breast tumors to anti-PD1
Tyler R McCaw, Mei Li, Dmytro Starenki, et al.
Breast Cancer Research and Treatment
|
April 3, 2015
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
Jennifer Stanley, Lisa Klepczyk, Kimberly Keene, et al.
Southern Medical Journal
|
November 3, 2020
Less Toxic Chemotherapy in Locally Advanced Breast Cancer
John Carpenter, Andres Forero, Carla I Falkson, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 30, 2007
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity
Pierre L Triozzi, Jatin J Shah, Wen-Quan Wang, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G Oliver, Albert F LoBuglio, Tong Zhou, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 179) with videos related to
Sort By:
Page
of 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 17, 2009
Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma
Sui Shen, Andres Forero, Ruby F Meredith, et al.
Annals of Hematology
|
January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma
Myron S Czuczman, Stephen Kahanic, Andres Forero, et al.
JCO Clinical Cancer Informatics
|
March 7, 2019
Visualization of Sequential Treatments in Metastatic Breast Cancer
Gabrielle B Rocque, Pravinkumar G Kandhare, Courtney P Williams, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 2, 2010
Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)
Andres Forero-Torres, Jatin Shah, Tina Wood, et al.
Journal of Oncology Practice
|
May 19, 2016
Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials
Mona N Fouad, Aras Acemgil, Sejong Bae, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2019
Histone deacetylase inhibition promotes intratumoral CD8<sup>+</sup> T-cell responses, sensitizing murine breast tumors to anti-PD1
Tyler R McCaw, Mei Li, Dmytro Starenki, et al.
Breast Cancer Research and Treatment
|
April 3, 2015
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
Jennifer Stanley, Lisa Klepczyk, Kimberly Keene, et al.
Southern Medical Journal
|
November 3, 2020
Less Toxic Chemotherapy in Locally Advanced Breast Cancer
John Carpenter, Andres Forero, Carla I Falkson, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 30, 2007
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity
Pierre L Triozzi, Jatin J Shah, Wen-Quan Wang, et al.
Breast Cancer Research and Treatment
|
September 9, 2011
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
Patsy G Oliver, Albert F LoBuglio, Tong Zhou, et al.
Page
of 18